pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
CD19 CAR-T cells and CD19 positive feeder T cells
Phase 2 · mab · Acute Lymphoblastic Leukemia in Remission
CD19 CAR-T cells and CD19 positive feeder T cells for Acute Lymphoblastic Leukemia in Remission is a Phase 2 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code UCT19-T19 v1.1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- mab
- Indication
- Acute Lymphoblastic Leukemia in Remission
- Status
- active
- Trials
- 1